News & Updates

Show Multimedia Only

OSA linked to thromboembolic event risk among women with PCOS

Women with polycystic ovarian syndrome (PCOS) may have an increased risk of thromboembolic events in the presence of obstructive sleep apnoea (OSA), according to a retrospective study.

OSA linked to thromboembolic event risk among women with PCOS

4 hours ago

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

10 hours ago

Cardiometabolic comorbidities have shown improvements following surgery in patients with Cushing syndrome (CS) and those with mild autonomous cortisol secretion (MACS), reports a study.

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

10 hours ago

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

16 hours ago

The use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) among adults with obesity and concomitant autoimmune diseases appears to lower the incidence of thromboembolic events, emergency department visits, and mortality, according to a study.

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

16 hours ago

Change in supine-to-standing SBP predicts mortality in females

17 Jun 2026

In healthy females, the change in supine-to-standing systolic blood pressure (SBP) is associated with mortality, regardless of traditional risk factors and antihypertensive medications, suggests a study.

Change in supine-to-standing SBP predicts mortality in females

17 Jun 2026

Which combo regimens are better tolerated for HTN?

17 Jun 2026 by

In a network meta-analysis of discontinuation of blood-pressure (BP)-lowering medications due to adverse effects (AEs), the best-tolerated treatment was a combination of an angiotensin receptor blocker (ARB) and a calcium channel blocker (CCB), with four of the top five best-tolerated regimens containing ARBs.

Which combo regimens are better tolerated for HTN?

17 Jun 2026

BAT offers modest BP-lowering effect in resistant hypertension

16 Jun 2026

Home blood pressure (BP) measurements have increased significantly following baroreflex activation therapy (BAT) deactivation, even after multiannual therapy, reports a study.

BAT offers modest BP-lowering effect in resistant hypertension

16 Jun 2026

Pilates training may reduce ambulatory BP in women with hypertension

16 Jun 2026

A Pilates Method (PM) program lasting for 13 weeks results in a decrease in ambulatory blood pressure (BP) and improvements in autonomic reflex responsiveness among women with hypertension, reports a recent study.

Pilates training may reduce ambulatory BP in women with hypertension

16 Jun 2026

Insomnia with short sleep duration linked to cardiovascular, cerebrovascular disease

14 Jun 2026

Individuals with insomnia with short sleep duration are at heightened risk of cardiovascular disease (CVD) and cerebrovascular disease (CBVD), according to a study.

Insomnia with short sleep duration linked to cardiovascular, cerebrovascular disease

14 Jun 2026

Low-dose rivaroxaban more harmful than beneficial in advanced CKD patients at high CV risk

13 Jun 2026

The use of low-dose rivaroxaban among patients with advanced chronic kidney disease (CKD) and high cardiovascular (CV) risk does little to reduce the risk of adverse CV events and may even contribute to increased bleeding events, according to the TRACK randomized clinical trial.

Low-dose rivaroxaban more harmful than beneficial in advanced CKD patients at high CV risk

13 Jun 2026

Original New Drug Application Approvals by US FDA (1-15 May 2026)

12 Jun 2026

New drug applications approved by US FDA as of 1-15 May 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 May 2026)

12 Jun 2026

News & Updates

Showing Cardiology articles

Showing

Specialty:

OSA linked to thromboembolic event risk among women with PCOS

OSA linked to thromboembolic event risk among women with PCOS

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

Change in supine-to-standing SBP predicts mortality in females

Change in supine-to-standing SBP predicts mortality in females

Which combo regimens are better tolerated for HTN?

Which combo regimens are better tolerated for HTN?

BAT offers modest BP-lowering effect in resistant hypertension

BAT offers modest BP-lowering effect in resistant hypertension

Pilates training may reduce ambulatory BP in women with hypertension

Pilates training may reduce ambulatory BP in women with hypertension

Insomnia with short sleep duration linked to cardiovascular, cerebrovascular disease

Insomnia with short sleep duration linked to cardiovascular, cerebrovascular disease

Low-dose rivaroxaban more harmful than beneficial in advanced CKD patients at high CV risk

Low-dose rivaroxaban more harmful than beneficial in advanced CKD patients at high CV risk

Original New Drug Application Approvals by US FDA (1-15 May 2026)

Original New Drug Application Approvals by US FDA (1-15 May 2026)